ACROTECH Company Profile
✉ Email this page to a colleague
What is the competitive landscape for ACROTECH, and when can generic versions of ACROTECH drugs launch?
ACROTECH has six approved drugs.
There are twelve US patents protecting ACROTECH drugs.
There are one hundred and seventy-nine patent family members on ACROTECH drugs in thirty-four countries and five supplementary protection certificates in four countries.
Drugs and US Patents for ACROTECH
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Acrotech Biopharma | KHAPZORY | levoleucovorin | POWDER;INTRAVENOUS | 211226-002 | Oct 19, 2018 | DISCN | Yes | No | 11,541,012 | ⤷ Sign Up | Y | ⤷ Sign Up | |||
Acrotech Biopharma | KHAPZORY | levoleucovorin | POWDER;INTRAVENOUS | 211226-001 | Oct 19, 2018 | RX | Yes | Yes | 11,541,012 | ⤷ Sign Up | Y | ⤷ Sign Up | |||
Acrotech Biopharma | FOLOTYN | pralatrexate | SOLUTION;INTRAVENOUS | 022468-001 | Sep 24, 2009 | RX | Yes | No | 7,622,470 | ⤷ Sign Up | ⤷ Sign Up | ||||
Acrotech Biopharma | FOLOTYN | pralatrexate | SOLUTION;INTRAVENOUS | 022468-002 | Sep 24, 2009 | RX | Yes | Yes | 7,622,470 | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for ACROTECH
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Acrotech Biopharma | FUSILEV | levoleucovorin calcium | SOLUTION;INTRAVENOUS | 020140-003 | Apr 29, 2011 | 6,500,829 | ⤷ Sign Up |
Acrotech Biopharma | FUSILEV | levoleucovorin calcium | SOLUTION;INTRAVENOUS | 020140-002 | Apr 29, 2011 | 6,500,829 | ⤷ Sign Up |
Acrotech | MARQIBO KIT | vincristine sulfate | INJECTABLE, LIPOSOMAL;INTRAVENOUS | 202497-001 | Aug 9, 2012 | 5,543,152 | ⤷ Sign Up |
Acrotech | MARQIBO KIT | vincristine sulfate | INJECTABLE, LIPOSOMAL;INTRAVENOUS | 202497-001 | Aug 9, 2012 | 6,723,338 | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Paragraph IV (Patent) Challenges for ACROTECH drugs
Drugname | Dosage | Strength | Tradename | Submissiondate |
---|---|---|---|---|
➤ Subscribe | Injection | 20 mg/mL and 40 mg/2 mL | ➤ Subscribe | 2013-09-24 |
➤ Subscribe | Injection | 50 mg/vial | ➤ Subscribe | 2017-09-08 |
➤ Subscribe | Injection | 50 mg/vial | ➤ Subscribe | 2013-12-19 |
➤ Subscribe | Injection | 500 mg/vial | ➤ Subscribe | 2018-07-03 |
➤ Subscribe | Injection | 10 mg/mL, 17.5 mL vial and 25 mL vial | ➤ Subscribe | 2011-10-26 |
International Patents for ACROTECH Drugs
Country | Patent Number | Estimated Expiration |
---|---|---|
Canada | 2865950 | ⤷ Sign Up |
Canada | 2565968 | ⤷ Sign Up |
Australia | 2013226073 | ⤷ Sign Up |
European Patent Office | 2292593 | ⤷ Sign Up |
>Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for ACROTECH Drugs
Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
---|---|---|---|---|
2701720 | CA 2022 00054 | Denmark | ⤷ Sign Up | PRODUCT NAME: MELPHALAN FLUFENAMIDE HYDROCHLORIDE; REG. NO/DATE: EU/1/22/1669 20220818 |
2701720 | 23C1000 | France | ⤷ Sign Up | PRODUCT NAME: MELPHALAN FLUFENAMIDE ET SES SELS PHARMACEUTIQUEMENT ACCEPTABLES, TELS QUE LE CHLORHYDRATE; REGISTRATION NO/DATE: EU/1/22/1669 20220818 |
2701720 | 122023000007 | Germany | ⤷ Sign Up | PRODUCT NAME: MELPHALANFLUFENAMID HYDROCHLORID; REGISTRATION NO/DATE: EU/1/22/1669 20220817 |
2701720 | CR 2022 00054 | Denmark | ⤷ Sign Up | PRODUCT NAME: MELPHALAN FLUFENAMIDE HYDROCHLORIDE; REG. NO/DATE: EU/1/22/1669 20220818 |
>Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Similar Applicant Names
Here is a list of applicants with similar names.